Previous Close | 11.21 |
Open | 11.11 |
Bid | 11.88 x 1100 |
Ask | 12.14 x 1300 |
Day's Range | 11.06 - 12.31 |
52 Week Range | 9.43 - 24.83 |
Volume | |
Avg. Volume | 111,713 |
Market Cap | 448.551M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.11 |
Earnings Date | Nov 10, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 31.75 |
Subscribe to Yahoo Finance Plus to view Fair Value for AURA
A look at the shareholders of Aura Biosciences, Inc. ( NASDAQ:AURA ) can tell us which group is most powerful. And the...
In this article, we will look at the 12 stocks insiders are buying now. If you want to explore similar stocks, you can also take a look at 5 Stocks Insiders are Buying Now. Investing in stocks that insiders are buying can sometimes lead to unexpected gains. Insiders, such as company executives, board members, and major […]
BOSTON, December 01, 2022--Aura Biosciences, Inc. ("Aura") (Nasdaq: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the pricing of an underwritten public offering of 6,700,000 shares of its common stock at a price to the public of $12.00 per share. The gross proceeds from the offering to Aura are expected to be $80.4 million, before deducting underwriting discounts and commissio